Maximilian Fliegauf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maximilian Fliegauf has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Marco Prinz
Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
4 shared publications - Lukas Amann
Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany
3 shared publications - Marius Schwabenland
Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2 shared publications - Maximilian Frosch
Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany
2 shared publications - Adrià Dalmau Gasull
Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany
1 shared publication Alexander Oschwald
Institute of Neuropathology, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany
1 shared publication
Latest Publications
- 25 March 2026
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (S3)
CNS border macrophages in health and disease
Subdural central nervous system (CNS)-associated macrophages (CAMs), encompassing macrophages of the leptomeninges and perivascular spaces, serve as the primary immune sentinels at the CNS interfaces. These cells have been suggested to be indispensable for maintaining homeostasis and orchestrating responses in pathological states. Under physiological conditions, CAMs continuously remodel the CNS borders, impact cerebrospinal fluid dynamics, uphold immune surveillance, and regulate cerebral blood flow through intricate interactions with mural and stromal cells. In disease, their roles diversify, encompassing the generation of reactive oxygen species, the regulation of blood-brain barrier (BBB) integrity, and the coordination of the local immune response. This review synthesizes contemporary insights into the molecular heterogeneity and context-specific functions of subdural CAMs, while exploring innovative therapeutic strategies targeting these cells.
- 25 March 2026
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (S3)
CNS border macrophages in health and disease
Subdural central nervous system (CNS)-associated macrophages (CAMs), encompassing macrophages of the leptomeninges and perivascular spaces, serve as the primary immune sentinels at the CNS interfaces. These cells have been suggested to be indispensable for maintaining homeostasis and orchestrating responses in pathological states. Under physiological conditions, CAMs continuously remodel the CNS borders, impact cerebrospinal fluid dynamics, uphold immune surveillance, and regulate cerebral blood flow through intricate interactions with mural and stromal cells. In disease, their roles diversify, encompassing the generation of reactive oxygen species, the regulation of blood-brain barrier (BBB) integrity, and the coordination of the local immune response. This review synthesizes contemporary insights into the molecular heterogeneity and context-specific functions of subdural CAMs, while exploring innovative therapeutic strategies targeting these cells.
- Top Cited PapersOpen Access
- 18 March 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (5) , 961-974
Distinct origins and niches determine the cellular responsiveness of CNS macrophages after repopulation
Nonparenchymal central nervous system (CNS)-associated macrophages (CAMs) mediate immune responses at brain boundaries. Perivascular and leptomeningeal CAMs are collectively termed subdural CAMs (sdCAMs). Both sdCAMs and juxtaneuronal microglia are derived from embryonic yolk sac precursors, long-living and maintain their populations through self-renewal. Following depletion, microglia autonomously repopulate from single surviving cells. In contrast, the course of sdCAM repopulation remains poorly understood. Here, by combining multilineage fate mapping, multiomic profiling and high-resolution imaging, we demonstrate divergent repopulation dynamics between sdCAMs and microglia. Unlike microglia, sdCAMs do not renew cell-autonomously, but become transiently accessible to CCR2 + Ly6C + monocyte engraftment after niche induction in an integrin-dependent manner. Moreover, replenished monocyte-derived sdCAMs remain transcriptomically, epigenetically and functionally distinct from their embryo-derived counterparts. Finally, we present a protocol enabling selective exchange of sdCAMs, modulating disease response without functionally affecting microglia. These new insights into CNS immune biology suggest new therapeutic avenues for neuroinflammatory and neurodegenerative diseases.
- 18 March 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (5) , 961-974
Top Cited PapersOpen AccessDistinct origins and niches determine the cellular responsiveness of CNS macrophages after repopulation
Nonparenchymal central nervous system (CNS)-associated macrophages (CAMs) mediate immune responses at brain boundaries. Perivascular and leptomeningeal CAMs are collectively termed subdural CAMs (sdCAMs). Both sdCAMs and juxtaneuronal microglia are derived from embryonic yolk sac precursors, long-living and maintain their populations through self-renewal. Following depletion, microglia autonomously repopulate from single surviving cells. In contrast, the course of sdCAM repopulation remains poorly understood. Here, by combining multilineage fate mapping, multiomic profiling and high-resolution imaging, we demonstrate divergent repopulation dynamics between sdCAMs and microglia. Unlike microglia, sdCAMs do not renew cell-autonomously, but become transiently accessible to CCR2 + Ly6C + monocyte engraftment after niche induction in an integrin-dependent manner. Moreover, replenished monocyte-derived sdCAMs remain transcriptomically, epigenetically and functionally distinct from their embryo-derived counterparts. Finally, we present a protocol enabling selective exchange of sdCAMs, modulating disease response without functionally affecting microglia. These new insights into CNS immune biology suggest new therapeutic avenues for neuroinflammatory and neurodegenerative diseases.
- Top Cited PapersOpen Access
- 6 August 2025
- Published by Springer Nature in Nature
- Vol. 646 (8086) , 913-924
Microglia–neuron crosstalk through Hex–GM2–MGL2 maintains brain homeostasis
As tissue-resident macrophages of the central nervous system parenchyma, microglia perform diverse essential functions during homeostasis and perturbations 1 . They primarily interact with neurons by means of synaptic engulfment and through the rapid elimination of apoptotic cells and non-functional synapses 2 . Here, by combining unbiased lipidomics and high-resolution spatial lipid imaging, deep single-cell transcriptome analysis and novel cell-type-specific mutants, we identified a previously unknown mode of microglial interaction with neurons. During homeostasis, microglia deliver the lysosomal enzyme β-hexosaminidase to neurons for the degradation of the ganglioside GM2 that is integral to maintaining cell membrane organization and function. Absence of Hexb , encoding the β subunit of β-hexosaminidase, in both mice and patients with neurodegenerative Sandhoff disease leads to a massive accumulation of GM2 derivatives in a characteristic spatiotemporal manner 3 . In mice, neuronal GM2 gangliosides subsequently engage the macrophage galactose-type lectin 2 receptor on microglia through N -acetylgalactosamine residues, leading to lethal neurodegeneration. Notably, replacement of microglia with peripherally derived microglia-like cells is able to break this degenerative cycle and fully restore central nervous system homeostasis. Our results reveal a mode of bidirectional microglia–neuron communication centred around GM2 ganglioside turnover, identify a microgliopathy and offer therapeutic avenues for these maladies.
- 6 August 2025
- Published by Springer Nature in Nature
- Vol. 646 (8086) , 913-924
Top Cited PapersOpen AccessMicroglia–neuron crosstalk through Hex–GM2–MGL2 maintains brain homeostasis
As tissue-resident macrophages of the central nervous system parenchyma, microglia perform diverse essential functions during homeostasis and perturbations 1 . They primarily interact with neurons by means of synaptic engulfment and through the rapid elimination of apoptotic cells and non-functional synapses 2 . Here, by combining unbiased lipidomics and high-resolution spatial lipid imaging, deep single-cell transcriptome analysis and novel cell-type-specific mutants, we identified a previously unknown mode of microglial interaction with neurons. During homeostasis, microglia deliver the lysosomal enzyme β-hexosaminidase to neurons for the degradation of the ganglioside GM2 that is integral to maintaining cell membrane organization and function. Absence of Hexb , encoding the β subunit of β-hexosaminidase, in both mice and patients with neurodegenerative Sandhoff disease leads to a massive accumulation of GM2 derivatives in a characteristic spatiotemporal manner 3 . In mice, neuronal GM2 gangliosides subsequently engage the macrophage galactose-type lectin 2 receptor on microglia through N -acetylgalactosamine residues, leading to lethal neurodegeneration. Notably, replacement of microglia with peripherally derived microglia-like cells is able to break this degenerative cycle and fully restore central nervous system homeostasis. Our results reveal a mode of bidirectional microglia–neuron communication centred around GM2 ganglioside turnover, identify a microgliopathy and offer therapeutic avenues for these maladies.
- Open Access
- 15 July 2025
- Published by Springer Nature in Cell Research
- Vol. 35 (12) , 930-931
Too sweet to be savory: how fructose elicits microglia-driven disturbance of neurodevelopment
- 15 July 2025
- Published by Springer Nature in Cell Research
- Vol. 35 (12) , 930-931
Open AccessToo sweet to be savory: how fructose elicits microglia-driven disturbance of neurodevelopment
- Open Access
- 28 March 2023
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 43 (17) , 3042-3060
Microglial Cytokines Mediate Plasticity Induced by 10 Hz Repetitive Magnetic Stimulation
Microglia, the resident immune cells of the CNS, sense the activity of neurons and regulate physiological brain functions. They have been implicated in the pathology of brain diseases associated with alterations in neural excitability and plasticity. However, experimental and therapeutic approaches that modulate microglia function in a brain region-specific manner have not been established. In this study, we tested for the effects of repetitive transcranial magnetic stimulation (rTMS), a clinically used noninvasive brain stimulation technique, on microglia-mediated synaptic plasticity; 10 Hz electromagnetic stimulation triggered a release of plasticity-promoting cytokines from microglia in mouse organotypic brain tissue cultures of both sexes, while no significant changes in microglial morphology or microglia dynamics were observed. Indeed, substitution of tumor necrosis factor α (TNFα) and interleukin 6 (IL6) preserved synaptic plasticity induced by 10 Hz stimulation in the absence of microglia. Consistent with these findings,in vivodepletion of microglia abolished rTMS-induced changes in neurotransmission in the mPFC of anesthetized mice of both sexes. We conclude that rTMS affects neural excitability and plasticity by modulating the release of cytokines from microglia.SIGNIFICANCE STATEMENTRepetitive transcranial magnetic stimulation (rTMS) is a noninvasive brain stimulation technique that induces cortical plasticity. Despite its wide use in neuroscience and clinical practice (e.g., depression treatment), the cellular and molecular mechanisms of rTMS-mediated plasticity remain not well understood. Herein, we report an important role of microglia and plasticity-promoting cytokines in synaptic plasticity induced by 10 Hz rTMS in organotypic slice cultures and anesthetized mice, thereby identifying microglia-mediated synaptic adaptation as a target of rTMS-based interventions.
- 28 March 2023
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 43 (17) , 3042-3060
Open AccessMicroglial Cytokines Mediate Plasticity Induced by 10 Hz Repetitive Magnetic Stimulation
Microglia, the resident immune cells of the CNS, sense the activity of neurons and regulate physiological brain functions. They have been implicated in the pathology of brain diseases associated with alterations in neural excitability and plasticity. However, experimental and therapeutic approaches that modulate microglia function in a brain region-specific manner have not been established. In this study, we tested for the effects of repetitive transcranial magnetic stimulation (rTMS), a clinically used noninvasive brain stimulation technique, on microglia-mediated synaptic plasticity; 10 Hz electromagnetic stimulation triggered a release of plasticity-promoting cytokines from microglia in mouse organotypic brain tissue cultures of both sexes, while no significant changes in microglial morphology or microglia dynamics were observed. Indeed, substitution of tumor necrosis factor α (TNFα) and interleukin 6 (IL6) preserved synaptic plasticity induced by 10 Hz stimulation in the absence of microglia. Consistent with these findings,in vivodepletion of microglia abolished rTMS-induced changes in neurotransmission in the mPFC of anesthetized mice of both sexes. We conclude that rTMS affects neural excitability and plasticity by modulating the release of cytokines from microglia.SIGNIFICANCE STATEMENTRepetitive transcranial magnetic stimulation (rTMS) is a noninvasive brain stimulation technique that induces cortical plasticity. Despite its wide use in neuroscience and clinical practice (e.g., depression treatment), the cellular and molecular mechanisms of rTMS-mediated plasticity remain not well understood. Herein, we report an important role of microglia and plasticity-promoting cytokines in synaptic plasticity induced by 10 Hz rTMS in organotypic slice cultures and anesthetized mice, thereby identifying microglia-mediated synaptic adaptation as a target of rTMS-based interventions.